Capricor Therapeutics (NasdaqCM:CAPR) Update / Briefing Transcript

Capricor Therapeutics (NasdaqCM:CAPR) Update / Briefing December 03, 2025 08:00 AM ET Company ParticipantsAJ Bergmann - CFONathan Hogan - Director of BiostatisticsCraig McDonald - Scientific AdvisorLinda Marban - CEOKristen Kluska - Managing DirectorCatherine Novack - DirectorJoe Pantginis - Director of Equity ResearchJohn Soslow - Professor of PediatricsConference Call ParticipantsNone - AnalystLeland Gershell - Managing Director and Senior AnalystAydin Huseynov - Equity Research AnalystBoobalan Pachaiyapp ...